DEA-MATE Training for Acute Care Clinicians - Special Offer

Enlarge Image
Delivery Method:	Online
$119.00 ADD TO CART Back To Store

Fulfill DEA Requirements About Opioid Use Training Now!

Overview

As of June 2023, all medical practitioners have been required to certify at their next scheduled DEA registration submission that they have completed an 8-hour training course on the treatment and management of patients with opioid or other substance use disorders. This course satisfies this training requirement, with a unique focus on the patients who present every day in the emergency department and the urgent care clinic, including adolescent as well as adult patients. In this course, you will learn:

Module 1: Pediatric Emergency Medicine Practice (4 hours): Substance Use in Adolescents: Recognition and Management in the Emergency Department

• Recommendations for prehospital management, including administration of prehospital naloxone; important information to gather at the scene and from friends, family, or bystanders; and options for managing agitation.
• Common acute presentations of frequently used substances.
• Limitations of urine drug screens, including common cross-reacting substances and drugs of abuse that do not commonly appear on basic urine drug screens.
• General treatment recommendations.
• The pathophysiology, presentation, and management of commonly used substances.
• Recommendations for ED disposition, including education and administration of take-home naloxone.

Module 2: Emergency Medicine Practice (4 hours): Managing Emergency Department Patients With Opioid Use Disorder (OUD)

• How to manage patients with opioid intoxication by recognizing the signs and treating respiratory and central nervous system depression: naloxone dosing, routes of administration, timing, and cautions.
• How to recognize and manage potential multidrug ingestions, and when CT imaging might be indicated.
• Strategies for recognizing when a patient is in opioid withdrawal, using the COWS score to calculate severity.
• The risks, benefits, and cautions for the 3 drugs approved for medication for OUD (MOUD): methadone, buprenorphine, and naltrexone.
• Initiating buprenorphine in the ED: when to start, recommended dosages according to opioids used, and avoiding precipitating withdrawal symptoms.
• Strategies for managing patients who are pregnant, in police custody, without stable housing, and currently using methadone, as well as the importance of follow-up care for these patients.
• New strategies in buprenorphine initiation: low-dose, high-dose, long-acting, and home initiation.

Learner Feedback